CGM in Primary Care: Bridging the Endocrinology Gap

Could continuous glucose monitoring (CGM) soon become the norm in primary care? Once considered a specialty tool reserved for endocrinologists, CGM is now recommended far earlier in diabetes treatment — even for patients with type 2 diabetes on basal insulin alone. Despite these guideline shifts, primary care adoption has lagged. This article explores why and, more importantly, offers practical steps to help non-specialist clinicians integrate CGM into routine diabetes care effectively.

Table of Contents

• Why CGM Matters Beyond Fingersticks
• CGM Now Recommended Earlier: What Guidelines Say
• Why Primary Care Has Lagged Behind — and What’s Changing
• Practical Steps for Integrating CGM into Routine Primary Care
• Conclusion
• Frequently Asked Questions

Why CGM Matters Beyond Fingersticks

Continuous glucose monitoring (CGM) has transformed diabetes care in recent years — offering far more than the occasional snapshot of a finger‑stick measurement. A CGM device monitors glucose levels continuously throughout the day and night. Instead of seeing one momentary reading, patients and clinicians obtain a stream of data points, enabling them to spot trends, detect post-meal spikes, nocturnal lows, or unrecognized hypoglycemia. Source

Because of this richer data, patients using CGM can make more informed decisions about meals, physical activity, and insulin or medication dosing. Alerts for impending highs or lows can help prevent dangerous events.

Moreover, CGM can improve long-term management. Studies have shown that use of CGM — compared to traditional self‑monitoring of blood glucose (SMBG) — is associated with improved glycemic control, reductions in hemoglobin A1c (HbA1c), and better detection of glucose variability. Source

CGM Now Recommended Earlier: What Guidelines Say

Guidelines from leading diabetes professional organizations have expanded to reflect growing evidence. The American Diabetes Association (ADA)’s 2024 Standards of Care in Diabetes recommend offering real‑time CGM (rtCGM) or intermittently scanned CGM (isCGM) for adults on any form of insulin therapy, including basal-only regimens. Source

Moreover, under some circumstances — such as frequent hypoglycemia, glycemic variability, or difficulty reaching glycemic targets — wider use of CGM is increasingly supported. Source

Thus, CGM is no longer reserved for “last‑resort” or “specialized” cases. Instead, it is recommended far earlier, making it an increasingly relevant tool for routine diabetes care — including in primary care settings.

Why Primary Care Has Lagged Behind — and What’s Changing

Despite the guideline support and proven benefits, the uptake of CGM in primary care remains limited. Surveys suggest a surprisingly low proportion of primary care physicians (PCPs) have prescribed CGM for their patients with type 2 diabetes. Source

In one recent national survey of PCPs (within a system that expanded CGM eligibility), many identified key obstacles: lack of experience interpreting CGM data, insufficient resources to manage CGM workflows, challenges with insurance coverage and paperwork, concerns about cost, and lack of support infrastructure (e.g., diabetes educators or device suppliers). Source

Nevertheless, momentum is shifting. A 2025 pilot implementation study showed that integrating CGM into primary care — using a multidisciplinary team approach with clinical pharmacists or diabetes‑education specialists — produced meaningful improvements in glycemic control. Source

Practical Steps for Integrating CGM into Routine Primary Care

1. Identify eligible patients. Begin by flagging patients who may benefit: those on insulin (basal or multiple daily injections), those with frequent hypoglycemia or glycemic variability, or those with suboptimal HbA1c despite therapy.

2. Build a support team. CGM adoption works best when supported by a multidisciplinary team — such as a primary care physician working alongside a certified diabetes care and education specialist (CDCES) or pharmacist. Source

3. Educate clinicians and staff. Training is often necessary to interpret CGM reports and translate them into actionable care plans. Clinics without nearby endocrinologists may benefit from workshops, CME modules, or consultation support.

4. Address insurance and logistics. One practical hurdle is device cost, prior authorization, and supply coverage. Clinics should engage early with payers, equipment suppliers, and support programs.

5. Use CGM data to guide care. Leverage metrics like time-in-range, variability, and glucose patterns — not just average blood sugar — to adjust treatment.

6. Reassess regularly. For ongoing success, CGM should be used consistently or at least periodically, depending on the device and patient situation. Source

Conclusion

CGM has matured from a niche tool reserved for endocrinology to a mainstream asset with powerful potential for routine diabetes care. As evidence grows and guidelines expand, the opportunity to close the gap between what is recommended and what is practiced becomes more real — especially in primary care settings. Implementing CGM may require workflow changes and team support, but real-world success is increasingly achievable.

Frequently Asked Questions

What types of patients are best suited for CGM in primary care?
Those on insulin, with hypoglycemia risk, glycemic variability, or persistent HbA1c elevations. Select non-insulin patients may also benefit.

Do physicians in primary care need special training to interpret CGM data?
Yes, training improves confidence and accuracy. Team-based models with diabetes educators or pharmacists can support integration.

Can CGM replace fingerstick glucose monitoring?
For many patients, yes. However, occasional confirmation by fingerstick may still be needed in some scenarios.

What are the main barriers to CGM uptake in primary care?
Lack of training, insurance coverage, workflow infrastructure, and device logistics remain the top challenges.

Is CGM cost‑effective?
It’s most cost-effective for patients on insulin or with significant glycemic issues, though affordability is improving as adoption grows.

This content is not medical advice. For any health issues, always consult a healthcare professional. In an emergency, call 911 or your local emergency services.